Opioid Induced Constipation Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

Publisher Name :
Date: 19-May-2020
No. of pages: 75

Summary

According to 99Strategy, the Global Opioid Induced Constipation Drugs Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Opioid Induced Constipation Drugs market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

- Asia Pacific

- North America

- Europe

- South America

- Middle East & Africa

Key Companies

- Ironwood Pharmaceuticals Inc

- Daiichi Sankyo Co Ltd

- Pfizer

- Progenics Pharmaceuticals Inc

- Shionogi & Co., Ltd

- Allergan Plc

- Nektar Therapeutics

- Purdue Pharma

- S.L.A. Pharma AG

- Mundipharma International Limited

- Ono Pharmaceutical Co., Ltd

- Takeda Pharmaceutical Company Limited

- Theravance Biopharma Inc

- Valeant Pharmaceuticals International

- Cosmo Pharmaceuticals SA

- Daewoong Pharmaceutical

- C.B. Fleet Company

- Sucampo Pharmaceuticals

Key Product Type

- Lubiprostone

- Methyl Naltrexone Bromide

- Naldemedine

- Alvimopan

- Others

Market by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Main Aspects covered in the Report

- Overview of the Opioid Induced Constipation Drugs market including production, consumption, status & forecast and market growth

- 2016-2020 historical data and 2021-2026 market forecast

- Geographical analysis including major countries

- Overview the product type market including development

- Overview the end-user market including development

- Impact of Coronavirus on the Industry

Opioid Induced Constipation Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

Table of Contents

1 Industrial Chain Overview
1.1 Opioid Induced Constipation Drugs Industry
1.1.1 Overview
Figure Opioid Induced Constipation Drugs Picture List
1.1.2 Characteristics of Opioid Induced Constipation Drugs
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Lubiprostone
1.3.2 Methyl Naltrexone Bromide
1.3.3 Naldemedine
1.3.4 Alvimopan
1.3.5 Others
1.4 End-Use List
1.4.1 Demand in Hospital Pharmacies
1.4.2 Demand in Retail Pharmacies
1.4.3 Demand in Online Pharmacies
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2016-2026
Figure Global Market Size and Forecast with Growth Rate, 2016-2026
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026
Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2016-2020, in Volume
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2016-2020, in Volume
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2016-2020, in Volume
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
3.2 Manufacturers List
3.2.1 Ironwood Pharmaceuticals Inc Overview
Table Ironwood Pharmaceuticals Inc Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Ironwood Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Daiichi Sankyo Co Ltd Overview
Table Daiichi Sankyo Co Ltd Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Daiichi Sankyo Co Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Pfizer Overview
Table Pfizer Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Progenics Pharmaceuticals Inc Overview
Table Progenics Pharmaceuticals Inc Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Progenics Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Shionogi & Co., Ltd Overview
Table Shionogi & Co., Ltd Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Shionogi & Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Allergan Plc Overview
Table Allergan Plc Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Allergan Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Nektar Therapeutics Overview
Table Nektar Therapeutics Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Nektar Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Purdue Pharma Overview
Table Purdue Pharma Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Purdue Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 S.L.A. Pharma AG Overview
Table S.L.A. Pharma AG Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of S.L.A. Pharma AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Mundipharma International Limited Overview
Table Mundipharma International Limited Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Mundipharma International Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Ono Pharmaceutical Co., Ltd Overview
Table Ono Pharmaceutical Co., Ltd Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Ono Pharmaceutical Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Takeda Pharmaceutical Company Limited Overview
Table Takeda Pharmaceutical Company Limited Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Takeda Pharmaceutical Company Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Theravance Biopharma Inc Overview
Table Theravance Biopharma Inc Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Theravance Biopharma Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Valeant Pharmaceuticals International Overview
Table Valeant Pharmaceuticals International Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Valeant Pharmaceuticals International (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Cosmo Pharmaceuticals SA Overview
Table Cosmo Pharmaceuticals SA Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Cosmo Pharmaceuticals SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Daewoong Pharmaceutical Overview
Table Daewoong Pharmaceutical Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Daewoong Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 C.B. Fleet Company Overview
Table C.B. Fleet Company Overview List
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of C.B. Fleet Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Sucampo Pharmaceuticals Overview
Table Sucampo Pharmaceuticals Overview List
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid Induced Constipation Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2016-2020, in Volume
Figure Global Market Size and Growth Rate, 2016-2020, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Figure Global Production Volume Share by Manufacturers in 2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Figure Global Production Amount Share by Manufacturers in 2020, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Lubiprostone
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Lubiprostone , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Lubiprostone , 2016-2020, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Methyl Naltrexone Bromide
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide , 2016-2020, in Volume
5.2.2.2 Situation & Development
5.2.3 Market in Naldemedine
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Naldemedine , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Naldemedine , 2016-2020, in Volume
5.2.3.2 Situation & Development
5.2.4 Market in Alvimopan
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Alvimopan , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Alvimopan , 2016-2020, in Volume
5.2.4.2 Situation & Development
5.2.5 Market in Others
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2016-2020, in Volume
5.2.5.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
6.2 Segment Subdivision
6.2.1 Market in Hospital Pharmacies
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2016-2020, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Retail Pharmacies
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2016-2020, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Online Pharmacies
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Online Pharmacies, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Online Pharmacies, 2016-2020, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2021-2026, in Million USD
Table Global Market Forecast by Region Segment 2021-2026, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
Table Global Market Volume by Product Type Segment 2021-2026, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
Table Global Market Volume by End-Use Segment 2021-2026, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Opioid Induced Constipation Drugs Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion

List of Tables

Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Ironwood Pharmaceuticals Inc Overview List
Table Opioid Induced Constipation Drugs Business Operation of Ironwood Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Daiichi Sankyo Co Ltd Overview List
Table Opioid Induced Constipation Drugs Business Operation of Daiichi Sankyo Co Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Opioid Induced Constipation Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Overview List
Table Opioid Induced Constipation Drugs Business Operation of Progenics Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Shionogi & Co., Ltd Overview List
Table Opioid Induced Constipation Drugs Business Operation of Shionogi & Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Allergan Plc Overview List
Table Opioid Induced Constipation Drugs Business Operation of Allergan Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Opioid Induced Constipation Drugs Business Operation of Nektar Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Purdue Pharma Overview List
Table Opioid Induced Constipation Drugs Business Operation of Purdue Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table S.L.A. Pharma AG Overview List
Table Opioid Induced Constipation Drugs Business Operation of S.L.A. Pharma AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Mundipharma International Limited Overview List
Table Opioid Induced Constipation Drugs Business Operation of Mundipharma International Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd Overview List
Table Opioid Induced Constipation Drugs Business Operation of Ono Pharmaceutical Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited Overview List
Table Opioid Induced Constipation Drugs Business Operation of Takeda Pharmaceutical Company Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Theravance Biopharma Inc Overview List
Table Opioid Induced Constipation Drugs Business Operation of Theravance Biopharma Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List
Table Opioid Induced Constipation Drugs Business Operation of Valeant Pharmaceuticals International (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals SA Overview List
Table Opioid Induced Constipation Drugs Business Operation of Cosmo Pharmaceuticals SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Daewoong Pharmaceutical Overview List
Table Opioid Induced Constipation Drugs Business Operation of Daewoong Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table C.B. Fleet Company Overview List
Table Opioid Induced Constipation Drugs Business Operation of C.B. Fleet Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sucampo Pharmaceuticals Overview List
Table Opioid Induced Constipation Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
Table Global Market Forecast by Region Segment 2021-2026, in Million USD
Table Global Market Forecast by Region Segment 2021-2026, in Volume
Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
Table Global Market Volume by Product Type Segment 2021-2026, in Volume
Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
Table Global Market Volume by End-Use Segment 2021-2026, in Volume

List of Figures

Figure Opioid Induced Constipation Drugs Picture List
Figure Global Market Size and Forecast with Growth Rate, 2016-2026
Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure Global Market Volume and Growth Rate, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure Middle East & Africa Prod
  • HIFU Cosmetic System Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 100
    HIFU cosmetic system uses ultrasound energy to encourage the production of collagen, which results in firmer skin. HIFU cosmetic systems are used for the safe descruoction of fat cells and removal of fat tissues. HIFU is a non-surgical skin treatment that uses ultrasound to actually lift muscle and tone loose or sagging skin without any downtime. This report contains market size and forecasts of HIFU Cosmetic System in US, including the following market information: US HIFU......
  • Non-invasive Glucose Monitoring Device Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 93
    Non-invasive glucose monitoring device could measure your glucose without hurt your finger. Non-invasive glucose monitoring device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma. This report contains market size and forecasts of Non-invasive Glucose Monitoring Device in US, including the following market inform......
  • N95 Grade Medical Protective Masks Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 104
    The N95 Grade Medical Protective Masks industry can be broken down into several segments, Flat-fold Type, Cup Style, etc. Across the world, the major players cover 3M, Honeywell, etc. N95 Grade Medical Protective Mask is a N95 respirator that is intended for use in a healthcare setting. The ‘N95' designation means that when subjected to careful testing, the respirator blocks at least 95 % of very small (0.3 micron) test particles. If properly fitted, the filtration capabilit......
  • DVT Pumps Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 107
    DVT Pumps are compression pumps designed to prevent people from getting deep vein thrombosis (DVT), which can be a life-threatening event. DVT Pumps work in such a way as to deliver the proper compression, so that blood within the arteries does no clot. This report contains market size and forecasts of DVT Pumps in US, including the following market information: US DVT Pumps Market Revenue, 2015-2020, 2021-2026, ($ millions) US DVT Pumps Market Consumption, 2015-2020......
  • Hazardous Drugs Closed System Transfer Device Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 94
    Hazardous Drugs Closed System Transfer Device is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration. This report contains market size and forecasts of Hazardous Drugs Closed System Transfer Device in US, including the foll......
  • Radiation Detection in Medical and Healthcare Market in US - Industry Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 103
    Radiation Detection In Medical and Healthcare report mainly focuses on dosimetry equipment, The dosimetry equipment is of fundamental importance in the disciplines of radiation dosimetry and radiation health physics and is primarily used to estimate the radiation dose deposited in an individual wearing the device. Due to the particularity of the dosimeter product, many players in the market earn money not only through the sales of dosimeters but also with service at the same time. For the OSL do......
  • Veterinary Patient Monitoring Equipment Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 94
    A veterinary monitoring device can be used to monitor heart rate, respiratory rate, blood pressure, oxygen saturation, end tidal carbon dioxide and body temperature, etc. These are mainly diagnostic devices used for the monitoring of various pet as well as wildlife animal population. This report contains market size and forecasts of Veterinary Patient Monitoring Equipment in US, including the following market information: US Veterinary Patient Monitoring Equipment Market Re......
  • Organ-on-a-Chip Market in US - Industry Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 102
    An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellu......
  • In-Vitro Colorectal Cancer Screening Tests Market in US - Industry Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 90
    In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer. This report contains market size and forecasts of In-Vitro Colorectal Cancer Screening Tests in US, including the following market information: US In-Vitro Colorectal Cancer Screening Tests Market Revenue, 2015-2020, 2021-2026, ($ millions) Top Five Competitors in US In-Vitro Colorectal Cancer Screening Tests Market 2019 (%) The global In......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs